The 5th Strategic Advisory Group of Experts on In Vitro Diagnostics (SAGE IVD) meeting will be held from the 25–29 November 2024. On the first day of the meeting, the WHO EDL Secretariat will hold an open webinar session with the participation of worldwide laboratory medicine professionals, nongovernmental organizations (NGOs) as well as representatives of member States and WHO regional offices, country offices, and headquarters.
In the subsequent days, the 2023 panel of SAGE IVD members will hold closed discussions on the applications received for the fifth WHO model list of essential in vitro diagnostics (EDL 5) as well as on the way forward for the EDL and its role in increasing availability, access and proper use of IVDs.
EDL 5 applications
Disclaimer
WHO publishes the applications as submitted by the applicants. The submitted applications may include references to specific companies or certain manufacturers’ products and/or contain package inserts. This does not mean in any way that they are endorsed or recommended by WHO in preference to others of a similar nature or that WHO provides any representation or warranty of any kind in relation thereof. WHO disclaims any and all liability whatsoever that may arise as a result of, or in connection with, the procurement, distribution, and use of any product referred to in the applications.